![Lloyd James Payne](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lloyd James Payne
Director/Board Member at Cyprotex Discovery Ltd.
Lloyd James Payne active positions
Companies | Position | Start | End |
---|---|---|---|
Cyprotex Discovery Ltd.
![]() Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Director/Board Member | - | - |
Career history of Lloyd James Payne
Former positions of Lloyd James Payne
Companies | Position | Start | End |
---|---|---|---|
CYPROTEX PLC | Director/Board Member | 15/03/2017 | - |
Statistics
International
United Kingdom | 3 |
Operational
Director/Board Member | 2 |
Sectoral
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Cyprotex Discovery Ltd.
![]() Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Commercial Services |
Cyprotex Ltd.
![]() Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Lloyd James Payne
- Experience